NMTC vs BVS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BVS Captures Institutional Edge (3โ1 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Bioventus Inc. Class A Common Stock (BVS) driven by superior Valuation, Growth & Margin, Momentum & Technical while NMTC counters with relative strength in Options & Structure. Fundamentally, NMTC trades at N/M Forward P/E with -63.4% operating margin (+16.3% YoY revenue) versus BVS at 11.1x Forward P/E and 10.1% operating margin (+2.7% YoY). In options structure, NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BVS sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NMTC Revenue | BVS Revenue | NMTC Op. Margin | BVS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2014 | $0M | N/A | -4646.1% | N/A | NMTC |
| FY2019 | N/A | $340M | N/A | 9.2% | BVS |
| FY2020 | N/A | $320M | N/A | 6.6% | BVS |
| FY2021 | $0M | $430M | -5735.9% | 2.8% | BVS |
| FY2022 | $0M | $510M | -5860.2% | -32.7% | BVS |
| FY2023 | $0M | $510M | -612.3% | -16.0% | BVS |
| FY2024 | $0M | $570M | -344.3% | -2.7% | BVS |
| FY2025 | $10M | $570M | -46.5% | 9.5% | BVS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NMTC | BVS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.1M | $681.3M | Larger Scale | BVS |
| Trailing P/E Ratio Valuation | N/M | 12.3x | Lower Multiple | BVS |
| Forward P/E Ratio Valuation | N/M | 11.1x | Lower Multiple | BVS |
| Revenue Growth (YoY) Growth | +16.3% | +2.7% | Higher Growth | NMTC |
| Operating Margin (TTM) Profitability | -63.4% | 10.1% | Higher Margin | BVS |
| Net Profit Margin Profitability | -59.7% | 9.8% | Higher Margin | BVS |
| Return on Equity (ROE) Capital Efficiency | -124.7% | 25.8% | Higher ROE | BVS |
| 52-Week Range Position Momentum | 2% ($1โ$5) | 36% ($6โ$16) | Stronger Trend | BVS |
| Beta / 30D Volatility Risk Regime | 1.55ฮฒ ยท 105% Vol | 0.85ฮฒ ยท 74% Vol | Lower Realized Risk | BVS |
| Unified Institutional Score Composite Signal | 45.5 / 100 (HOLD) | 46.2 / 100 (HOLD) | Higher Composite | BVS |